DAX
18.273,01 +109,49 (+0,60%) Euro Stoxx 50
4.945,27 +37,97 (+0,77%) Dow Jones 30
39.150,33 +15,53 (+0,04%) Gold
2.339,10 +7,90 (+0,34%) EUR/USD
1,0733 +0,0036 (+0,33%) Bitcoin EUR
56.958,13 -2.937,82 (-4,90%)
BICO Group AB (publ) (BICO.ST)
BICO Group AB (publ)
Långfilsgatan 9
Gothenburg 412 77
Sweden
46 7 35 46 57 77
https://www.bico.com
Sektor(en): Healthcare
Branche: Medical Devices
Vollzeitmitarbeiter: 837
Beschreibung
BICO Group AB (publ) operates as a bioconvergence company in North America, Europe, Asia, and internationally. It operates through three segments: Bioprinting, Biosciences, and Bioautomation. The Bioprinting segment offers products, solutions, and services that enable proliferation of 3D cell culture and 3D printing. The Biosciences segment provides instruments that enable the handling of cells and rare samples, and rapid transfer of liquids and reagents, as well as downstream analysis platforms. The Bioautomation segment offers end-to-end products and services in precision dispensing, advanced sample preparation, multiplex analysis and assay miniaturization, diagnostic and medical device manufacturing for life science and diagnostic industries. It primarily serves medical, pharmaceutical, and cosmetic industries. The company offers its products through sales organizations, as well as through an extensive distributor network. The company was formerly known as Cellink AB (publ) and changed its name to BICO Group AB (publ) in August 2021. BICO Group AB (publ) was incorporated in 2016 and is headquartered in Gothenburg, Sweden.
Corporate Governance
BICO Group AB (publ)s ISS Governance QualityScore, Stand 1. Juni 2024, lautet 5. Die grundlegenden Scores sind Audit: 4, Vorstand: 1, Shareholderrechte: 7, Kompensation: 10.
